In another study, the treatment of androgen receptor-positive prostate cancer cells with icariside II resulted in downregulation of expression of KLK3 gene, showing the role of icariside II in inhibition of AR signaling (Miura et al., 2015). The gene discussed is AR; the disease is prostate cancer.